213 related articles for article (PubMed ID: 12080287)
1. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
[TBL] [Abstract][Full Text] [Related]
2. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
3. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
4. [Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia].
Yang J; Zhao ZH; Qian YH; Hu XD; Li M; Zong CH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1801-4. PubMed ID: 18158987
[TBL] [Abstract][Full Text] [Related]
5. Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.
Reglodi D; Fábián Z; Tamás A; Lubics A; Szeberényi J; Alexy T; Tóth K; Márton Z; Borsiczky B; Rõth E; Szalontay L; Lengvári I
Regul Pept; 2004 Dec; 123(1-3):51-9. PubMed ID: 15518893
[TBL] [Abstract][Full Text] [Related]
6. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats.
Yang J; Song TB; Zhao ZH; Qiu SD; Hu XD; Chang L
Brain Res; 2011 Jun; 1398():94-101. PubMed ID: 21620378
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
[TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
11. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
12. Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.
Reglodi D; Tamás A; Somogyvári-Vigh A; Szántó Z; Kertes E; Lénárd L; Arimura A; Lengvári I
Peptides; 2002 Dec; 23(12):2227-34. PubMed ID: 12535703
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
[TBL] [Abstract][Full Text] [Related]
14. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide.
Ekelund M; Ekblad E
Scand J Gastroenterol; 2001 Mar; 36(3):251-7. PubMed ID: 11305511
[TBL] [Abstract][Full Text] [Related]
15. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
16. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
17. [Vasoactive intestinal peptide attenuates apoptosis and iNOS protein expression induced by cerebral ischemia in the rat].
Yang J; Zong CH; Wang WX; Hu XD; Li M; Chen GM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):563-6. PubMed ID: 18798494
[TBL] [Abstract][Full Text] [Related]
18. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
19. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
[TBL] [Abstract][Full Text] [Related]
20. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.
Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J
Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
